title: Efficacy of reversal of aortic calcification by chelating agents.
abstract: Elastin-specific medial vascular calcification, termed "Monckeberg's sclerosis," has been recognized as a major risk factor for various cardiovascular events. We hypothesize that chelating agents, such as disodium ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), and sodium thiosulfate (STS) might reverse elastin calcification by directly removing calcium from calcified tissues into soluble calcium complexes. We assessed the chelating ability of EDTA, DTPA, and STS on removal of calcium from hydroxyapatite (HA) powder, calcified porcine aortic elastin, and calcified human aorta in vitro. We show that both EDTA and DTPA could effectively remove calcium from HA and calcified tissues, while STS was not effective. The tissue architecture was not altered during chelation. In the animal model of aortic elastin-specific calcification, we further show that local periadventitial delivery of EDTA loaded in to poly(lactic-co-glycolic acid) nanoparticles regressed elastin-specific calcification in the aorta. Collectively, the data indicate that elastin-specific medial vascular calcification could be reversed by chelating agents.
authors: Department of Bioengineering, Clemson University, 501 Rhodes Engineering Research Center, Clemson, SC, 29634, USA.
authors: Yang
authors: Y
authors: Lei
authors: Arjun
authors: A
authors: Grover
authors: Aditi
authors: A
authors: Sinha
authors: Naren
authors: N
authors: Vyavahare
mesh_terms: D000368:Aged; D000818:Animals; D001018:Aortic Diseases / Q000188:drug therapy* / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004492:Edetic Acid / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D004369:Pentetic Acid / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D013552:Swine; D016896:Treatment Outcome; D061205:Vascular Calcification / Q000188:drug therapy* / Q000473:pathology
chemical_list: D002614:Chelating Agents; D004369:Pentetic Acid; D004492:Edetic Acid; D002118:Calcium
references: Am Heart J. 2012 Jan;163(1):7-12
references: 22172430
references: Adv Exp Med Biol. 1974;43(0):173-91
references: 4599722
references: Semin Dial. 2007 Mar-Apr;20(2):103-9
references: 17374082
references: Regul Pept. 2010 Jan 8;159(1-3):35-43
references: 19766150
references: Circulation. 1999 Nov 23;100(21):2168-76
references: 10571976
references: Int J Cardiovasc Imaging. 2009 Aug;25(6):615-24
references: 19363656
references: Kidney Int. 2008 Dec;74(11):1444-53
references: 18818688
references: Nephrol Dial Transplant. 2010 Jun;25(6):1923-9
references: 20083471
references: Am J Pathol. 1999 Sep;155(3):973-82
references: 10487855
references: JAMA. 2013 Mar 27;309(12):1241-50
references: 23532240
references: Int J Clin Pract. 2008 Dec;62(12):1821-2
references: 19166425
references: Circulation. 2004 Nov 30;110(22):3480-7
references: 15545515
references: Circulation. 2007 Dec 4;116(23):2762-72
references: 17998462
references: Complement Ther Clin Pract. 2006 Aug;12(3):213-5
references: 16835033
references: Medscape J Med. 2008 May 13;10(5):115
references: 18596934
references: Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2110-6
references: 16840714
references: Am J Pathol. 2006 Feb;168(2):490-8
references: 16436663
references: Curr Opin Pharmacol. 2009 Apr;9(2):84-9
references: 19157979
references: Dan Med Bull. 1993 Nov;40(5):627-30
references: 8299406
references: Biol Trace Elem Res. 2001 Dec;83(3):207-21
references: 11794513